Original Article ING5 inhibits epithelial-mesenchymal transition in
30 sept. 2015 Original Article. ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway. Qing-Ye Zhao1 Fang Ju1
ING5 inhibits lung cancer invasion and epithelialâ•fimesenchymal
22 janv. 2019 ORIGINAL ARTICLE. ING5 inhibits lung cancer invasion and epithelial– mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in
EMT epithelial-to-mesenchymal transition; FBS
LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth
relationship between miR-222 and CASC2 or ING5 was confirmed using Ma XZ Zhao H. ING5 inhibits epithelial-mesenchymal transition in breast cancer by.
s y
A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant
4 août 2021 are an indicator of epithelial–mesenchymal transition (EMT) ... Keywords: prostate cancer; plant homeodomain; inhibitor of growth 3.
ING5 is a Potential Target for Osteosarcoma Therapy
5 could induce apoptosis and inhibit cell proliferation in osteosarcoma cells. epithelialmesenchymal transition in breast cancer by suppres-.
ING5 activity in self-renewal of glioblastoma stem cells via calcium
18 sept. 2017 ING5 increases the stem cell pool and inhibits differentiation ... epithelial-mesenchymal transition and invasion through the ERK1/2 ...
onc ?origin=ppub
ING Tumour Suppressors and ING Splice Variants as Coregulators
29 sept. 2021 Accordingly ING5 also inhibits EMT since the loss of ING5 expression in lung cancer enhanced migration and invasion through activation of EGFR/ ...
Role of MicroRNAs in Signaling Pathways Associated with the
14 juin 2022 [63] using TGFβ
E-cadherin on epithelial–mesenchymal transition in thyroid cancer
However the low expression of tumor suppres- sor genes miR-146b and ING5 in thyroid carcinoma can not inhibit the expression of PI3K/AKT
s